In the last trading session, 1.37 million shares of the Revolution Medicines Inc (NASDAQ:RVMD) were traded, and its beta was 1.46. Most recently the company’s share price was $36.26, and it changed around -$0.17 or -0.47% from the last close, which brings the market valuation of the company to $5.97B. RVMD currently trades at a discount to its 52-week high of $38.73, offering almost -6.81% off that amount. The share price’s 52-week low was $15.44, which indicates that the current value has risen by an impressive 57.42% since then. We note from Revolution Medicines Inc’s average daily trading volume that its 3-month average coming to 1.44 million.
Revolution Medicines Inc (NASDAQ:RVMD) trade information
Instantly RVMD has showed a red trend with a performance of -0.47% at the end of last trading. The performance over the last five days has remained in the green territory. The company’s shares are currently up 26.43% year-to-date, but still up 0.03% over the last five days. On the other hand, Revolution Medicines Inc (NASDAQ:RVMD) is 17.46% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $45.5, which translates to bulls needing to increase their stock price by 20.31% from its current value. Analyst projections state that RVMD is forecast to be at a low of $43 and a high of $48.
Revolution Medicines Inc (RVMD) estimates and forecasts
Revolution Medicines Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 29.64 percent over the past six months and at a 17.62% annual growth rate that is well above the industry average of 10.20%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will loss -4.20% in revenue this quarter, and will report an increase of 15.20% in the next quarter. The year-over-year growth rate is expected to be -34.50%, down from the previous year.
Consensus estimates provided by 10 financial analysts predict the company will bring in an average of $1.44 million in revenue for the current quarter. 10 analysts expect Revolution Medicines Inc to make $1.48 million in revenue for the quarter ending Jun 2024. The company’s sales for the same quarters a year ago were $7.01 million and $3.82 million respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -79.50%. Forecasts for the next quarter put sales growth at -61.30%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -36.05%.
RVMD Dividends
Revolution Medicines Inc’s next quarterly earnings report is expected to be released in May.
